Special Issue "Neuroactive Compounds"

Quicklinks

A special issue of Pharmaceuticals (ISSN 1424-8247).

Deadline for manuscript submissions: closed (31 December 2010)

Special Issue Editor

Guest Editor
Dr. Maurice Tangui
INSERM U. 710, University of Montpellier 2, 34095 Montpellier cedex 5, France
Website: http://www.mmdn.univ-montp2.fr/equipe2.html
E-Mail: tangui.maurice@univ-montp2.fr

Special Issue Information

Dear Colleagues,

Research in Neuroscience has never been so active, taking benefits from recent developments in functional imaging, molecular biology and transgenesis, or improvements in animals’ cognitive behavioral analyses. Paradoxically, validation of new therapeutic strategies and marketing of really innovative medicine against pathologies with major social issues like Alzheimer’s disease and related neurodegenerative disorders, ischemic insults, depression, or schizophrenia mark time and do not find way out in a near future. Drug development pipelines of pharmaceutical companies remain alarmingly empty.
This combined Special Issue of Molecules and Pharmaceuticals, on Neuroactive Compounds, will offer an unique forum to present the chemistry, pharmacology and therapeutic opportunities offered by new and innovative molecular series in all areas of neuropharmacology and neuroscience. I strongly encourage authors to submit papers for this special issue, within the scope of Molecules and Pharmaceuticals, and I hope that the fields covered will allow to rise our hopes in seeing soon the validation of breakthrough treatments in central pathologies of major concern.

Dr. Tangui Maurice
Guest Editor

Keywords

  • psychoactive drugs
  • neuroprotective agents
  • antidepressant
  • anxiolytics
  • anti-stress drugs
  • brain imaging tools
  • brain penetration
  • blood-brain barrier agents

Related Special Issue

Published Papers (2 papers)

by , , ,  and
Pharmaceuticals 2011, 4(2), 382-418; doi:10.3390/ph4020382
Received: 29 December 2010; in revised form: 3 February 2011 / Accepted: 12 February 2011 / Published: 18 February 2011
Show/Hide Abstract | Cited by 6 | PDF Full-text (381 KB) | HTML Full-text | XML Full-text

by  and
Pharmaceuticals 2010, 3(11), 3371-3416; doi:10.3390/ph3113371
Received: 31 August 2010; in revised form: 5 October 2010 / Accepted: 25 October 2010 / Published: 28 October 2010
Show/Hide Abstract | Cited by 3 | PDF Full-text (916 KB) | HTML Full-text | XML Full-text
abstract graphic

Last update: 8 August 2014

Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert